Reversal of thiamine deficiency-induced neurodegeneration

被引:76
作者
Ke, ZJ
DeGiorgio, LA
Volpe, BT
Gibson, GE
机构
[1] Cornell Univ, Weill Med Coll, Burke Med Res Inst, White Plains, NY 10605 USA
[2] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, White Plains, NY USA
关键词
F4/80; fluoro-jade; hemeoxygenase-1; microglia; NeuN; neurodegeneration; thiamine;
D O I
10.1093/jnen/62.2.195
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurodegenerative diseases are characterized by abnormalities in oxidative processes, region-selective neuron loss, and diminished thiamine-dependent enzymes. Thiamine deficiency (TD) diminishes thiamine dependent enzymes, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death. In mice, the time course of TD-induced changes in neurons and microglia were determined in the brain region most sensitive to TD. Significant neuron loss (29%) occurred after 8 or 9 days of TD, (TD8-9) and increased to 90% neuron loss by TD10-11. The number of microglia increased 16% by TD8 and by nearly 400% on TD11. Hemeoxygenase-1 (HO-1)-positive microglia were not detectable at TD8, yet increased dramatically coincident with neuron loss. To test the duration of TD critical for irrevocable changes, mice received thiamine after various durations of TD. Thiamine administration on TD8 blocked further neuronal loss and induction of HO-1-positive microglia, whereas other microglial changes persisted. Thiamine only partially reversed effects on TD9, and was ineffective on TD10-11. These studies indicate that irreversible steps leading to neuronal death and induction of HO-1-positive microglia occur on TD9. The results indicate that TD induces alterations in neurons, endothelial cells, and microglia contemporaneously. This model provides a unique paradigm for elucidating the molecular mechanisms involved in neuronal commitment to neuronal death cascades and contributory microglial activity.
引用
收藏
页码:195 / 207
页数:13
相关论文
共 42 条
[11]   Increased mast cell degranulation within thalamus in early pre-lesion stages of an experimental model of Wernicke's encephalopathy [J].
Ferguson, M ;
Dalve-Endres, AM ;
McRee, RC ;
Langlais, PJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (07) :773-783
[12]  
Franklin K B J, 2008, MOUSE BRAIN STEREOTA
[13]   Stress response to hypoxia in gerbil brain: HO-1 and MnSOD expression and glial activation [J].
Garnier, P ;
Demougeot, C ;
Bertrand, N ;
Prigent-Tessier, A ;
Marie, C ;
Beley, A .
BRAIN RESEARCH, 2001, 893 (1-2) :301-309
[14]   Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits [J].
Gibson, GE ;
Park, LCH ;
Zhang, H ;
Sorbi, S ;
Calingasan, NY .
OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 :79-94
[15]   The α-ketoglutarate dehydrogenase complex in neurodegeneration [J].
Gibson, GE ;
Park, LCH ;
Sheu, KFR ;
Blass, JP ;
Calingasan, NY .
NEUROCHEMISTRY INTERNATIONAL, 2000, 36 (02) :97-112
[16]   α-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation [J].
Gibson, GE ;
Zhang, H ;
Sheu, KFR ;
Bogdanovich, N ;
Lindsay, JG ;
Lannfelt, L ;
Vestling, M ;
Cowburn, RF .
ANNALS OF NEUROLOGY, 1998, 44 (04) :676-681
[17]   Abnormalities of mitochondrial enzymes in Alzheimer disease [J].
Gibson, GE ;
Sheu, KFR ;
Blass, JP .
JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (8-9) :855-870
[18]  
Gibson GE, 2001, J NEUROCHEM, V78, P132
[19]   Bioenergetics in Huntington's disease [J].
Grünewald, T ;
Beal, MF .
OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 :203-213
[20]   Immediate-early gene expression in the brain of the thiamine-deficient rat [J].
Hazell, AS ;
McGahan, L ;
Tetzlaff, W ;
Bedard, AM ;
Robertson, GS ;
Nakabeppu, Y ;
Hakim, AM .
JOURNAL OF MOLECULAR NEUROSCIENCE, 1998, 10 (01) :1-15